Andrew Rosner, MBA
Vice President, Real-World & Late Phase
Syneos Health, Toronto, Canada

Andrew has more than 20 years of experience as a global healthcare professional with a successful record of implementing international business and research strategies throughout North America, Europe and Asia Pac. Over his career, Andrew has designed and implemented numerous observational, health economic and outcomes projects many of which are published in peer reviewed journals including Quality of Life Research, Can J Infect Dis, Can J Clin Pharmacol, and Pharmacoeconomics. In his role at Syneos Health, Andrew assists clients with the design and execution of real world research and leads study design and protocol development to ensure alignment of study outcomes and commercial objectives. Andrew has a focus on leveraging fit for purpose data and technology to address many of the pain points within real world research projects. He has a degree in pharmacology and biology, an MBA in health services management and is a member of team developing the future digital strategic roadmap for Syneos Health.